Picture of Klaria Pharma Holding AB (publ) logo

KLAR — Klaria Pharma Holding AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Klaria Pharma Gets Approval For Study With Sumatriptan Alginatfilm

Nov 12 (Reuters) - Klaria Pharma Holding AB (publ)
 KLAR.ST :
    * RECEIVES REGULATORY APPROVAL FOR STUDY WITH SUMATRIPTAN
ALGINATFILM
    * - TO BEGIN CLINICAL STUDY, CONFIRMS PREVIOUSLY
COMMUNICATED TIME
FRAME WITH EXPECTED RESULTS IN Q1 2021

Source text for Eikon:  ID:nWkr6bn6dK 
Further company coverage:  KLAR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Klaria Pharma Holding AB (publ)

See all news